Evidence map›Paper›PMID 21308845›Full record

ArticleProtein science : a publication of the Protein Society2011

A secretory system for bacterial production of high-profile protein targets.

Alexander Kotzsch, Erik Vernet, Martin Hammarström, Jens Berthelsen, Johan Weigelt, Susanne Gräslund, Michael Sundström

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Extracellular production of Ulp1Applied microbiology and biotechnology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Folding Optimization In Vivo Uncovers New Chaperones.Journal of molecular biology · 2015
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander KotzschFacility for Protein Science and Technology, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark. alexander.kotzsch@cpr.ku.dk
Erik Vernet
Martin Hammarström
Jens Berthelsen
Johan Weigelt
Susanne Gräslund
Michael Sundström

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli represents a robust, inexpensive expression host for the production of recombinant proteins. However, one major limitation is that certain protein classes do not express well in a biologically relevant form using standard expression approaches in the cytoplasm of E. coli. To improve the usefulness of the E. coli expression platform we have investigated combinations of promoters and selected N-terminal fusion tags for the extracellular expression of human target proteins. A comparative study was conducted on 24 target proteins fused to outer membrane protein A (OmpA), outer membrane protein F (OmpF) and osmotically inducible protein Y (OsmY). Based on the results of this initial study, we carried out an extended expression screen employing the OsmY fusion and multiple constructs of a more diverse set of human proteins. Using this high-throughput compatible system, we clearly demonstrate that secreted biomedically relevant human proteins can be efficiently retrieved and purified from the growth medium.

Indexed as

Bacterial Outer Membrane ProteinsBacterial Secretion SystemsEscherichia coliEscherichia coli ProteinsHumansMass SpectrometryPeriplasmic Binding ProteinsPorinsPromoter Regions, GeneticRecombinant Fusion ProteinsBacterial Outer Membrane ProteinsBacterial Secretion SystemsEscherichia coli ProteinsOMPA outer membrane proteinsOmpF proteinosmY protein, E coliPeriplasmic Binding ProteinsPorinsRecombinant Fusion Proteins

Identifiers

PMID21308845
PMCPMC3064838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.